ASPEN PHARMACARE HOLDINGS LIMITED - Appointment of Linda de Beer as Chairman of the Remuneration & Nomination Committee

Appointment of Linda de Beer as Chairman of the Remuneration & Nomination Committee

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings” or “the Company”)
Registration number: 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
and its subsidiaries (collectively “Aspen” or “the Group”)


Appointment of Linda de Beer as Chairman of the Remuneration & Nomination Committee


The Board of Aspen is pleased to announce that it has appointed Ms Linda de Beer to succeed
Mr Roy Andersen as the Chairman of the Company’s Remuneration & Nomination Committee
(“the Committee”) with effect from 6 December 2018. Mr Andersen will remain a member of
this Committee.

The Board wishes to express its sincere appreciation for Mr Andersen’s many years of dedicated
service to Aspen in his capacity as Chairman of this Committee and to wish Ms de Beer all the
best in her new role.


Durban
7 December 2018


Sponsor
Investec Bank Limited

Date: 07/12/2018 11:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.